Novel illicit opioids,such as furanyl fentanyl and U-47700, are being encountered with increasing frequency in street heroin samples and have been confirmed in a series of overdose deaths in Tennessee. In this paper, we report the pathology and toxicology from 11 deaths involving furanyl fentanyl and U-47700. Routine toxicology was performed on postmortem femoral or antemortem hospital blood samples with targeted broad spectrum drug screening using liquid chromatography-time-of-flight mass spectrometry (LC-TOF/MS). Confirmation and quantitation of the opioid agonists U-47700 and furanyl fentanyl was performed by ultra-high-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) using a novel method. Two cases were identified as containing U-47700 in whole blood (189 and 547 ng/mL), and nine cases contained furanyl fentanyl in whole blood, with concentrations ranging from 2.0 -42.9 ng/mL. In all 11 cases, the manner of death was deemed accident, with drug intoxication being the primary cause of death; one case was complicated by smoke inhalation. All of the decedents were males ranging from 18-62 years, with the median age being 36 years old. The successful identification and confirmation of these novel illicit opioids in this case series relied on the comprehensive investigation and collaboration of scene investigation, forensic pathology, and forensic toxicology.
INTRODUCTION
Within the past few years, there has been an increase in drug-related overdoses caused by novel illicit opioids across the US (1, 2) . The trend is believed to have been fueled by an increased demand for heroin, the availability of other prescription painkillers like oxycodone, and the expansion of the research for chemical or novel psychoactive substance (NPS) movement, which has expanded from synthetic cannabinoids and cathinone-derived stimulants, to include novel potent opioid agonists (3) (4) (5) and benzodiazepines (6) . These developments have opened up additional opportunities for recreational drug use while circumventing routine toxicology testing and evading scheduling legislation. The novel illicit opioids include compounds culled from pharmaceutical research patents and pharmaceutical company catalogs from initiatives in finding alternatives to morphine and by chemically tweaking popular analgesic drugs like fentanyl. The first fentanyl analog to achieve recreational popularity was acetyl fentanyl (7, 8) , followed by butyryl fentanyl (9) (10) (11) (12) . Novel compounds sourced from pharmaceutical research that have been implicated in fatalities include MT-45 (4, 13) and AH-7921 (5, (14) (15) (16) (17) . Structures of these and related compounds are shown in Figure 1 .
Beginning in 2015 and continuing through 2016, two of these novel opioids, furanyl fentanyl and U-47700 (Figure 1) , were encountered in postmortem toxicology casework in Tennessee, with the first case being encountered in May 2015. Furanyl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylfuran-2-carboxamide, "Fu-F") is a fentanyl derivative that differs from fentanyl in that it has a furanyl ring in place of the methyl group adjacent to the carbonyl bridge (Figure 1) . Furanyl fentanyl has a median effective dose, or ED50, in mice of 0.02 mg/kg (18) , which is comparable to that of fentanyl (0.016 mg/kg) (19) . The second chemical, U-47700 (trans-3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide) (Figure 1) is an opioid analgesic drug developed by the pharmaceutical company Upjohn in the 1970's that has a structure unrelated to morphine; however, it is a structural analog of AH-7921, an earlier experimental opioid agonist developed by the drug company, Allen and Hanbury, that has been implicated in earlier referenced fatalities (20) . U-47700 is a selective µ-opioid receptor agonist and in animal models has been demonstrated to have approximately 7.5 times the potency of morphine (21, 22) , while fentanyl has a potency of 50 to 100 times that of morphine.
As with most of these novel illicit opioids, the effects of U-47700 and furanyl fentanyl have not been studied in humans. However, based on preclinical testing, the compounds are expected to produce effects similar to those of other opioid agonists, such as analgesia, sedation, euphoria, and respiratory depression. Naloxone has proven to be an appropriate antidote in overdoses related to U-47700, which further supports the proposition that U-47700 is an opioid receptor agonist (23) . There have been several recent reports of deaths associated with both furanyl fentanyl and U-47700 (3, (23) (24) (25) (26) . These deaths typically appear as routine intravenous drug deaths with drug paraphernalia found at the scene and indicators at autopsy including pulmonary edema, which is frequently seen in opioid deaths. Due to the lack of clinical data, case series of human intoxications and fatalities help to provide critical information to the scientific community.
Throughout 2016, a number of case reports involving both novel illicit opioids emerged, highlighting the danger these substances pose. Subsequently, U-47700 and furanyl fentanyl were scheduled by the US Drug Enforcement Administration (DEA) in November of 2016 (27, 28) . Despite domestic efforts to control these compounds, they continue to be implicated in drug-related deaths. China recently listed the intention of controlling the export of furanyl fentanyl, along with carfentanil, valeryl fentanyl, and acryl fentanyl as of March 2017 (29) . It is unknown at this time what the effect that ban will have on the availability of these compounds in the US.
METHODS
Specialized toxicological testing for furanyl fentanyl and U-47700 was pursued in a set of 11 cases from Tennessee in which there was an indication of a novel illicit opioid from scene investigation and/or preliminary testing did not reveal the presence of a suspected opiate.
In nine of the 11 cases, femoral blood was collected in gray top tubes during forensic autopsies performed in suspected drug deaths. One additional case was submitted as an antemortem peripheral blood specimen in a blue top vial and a second case was submitted as hospital blood in a light blue top vial. Blue and light blue top tubes with a citrate preservative are typically specimen containers for diagnostic tests; however, these samples become evidentiary if an individual dies in the hospital during treatment, which occurred in these two cases. Blood specimens were stored refrigerated and then transferred to the laboratory for toxicological analysis.
Toxicological Screening of Postmortem Samples
Routine drug screening for over 330 common prescription and recreational drugs using enzyme-linked immunosorbent assay (ELISA) for salicylates, barbiturates, and cannabinoids, and liquid chromatography time-of-flight (LC-TOF) mass spectrometry was performed. A volatiles screen for ethanol, methanol, acetone, and isopropanol was also performed using headspace gas chromatography with flame ionization detection (HS-GC/FID). Additional supplemental testing for drugs outside the scope of the screening analysis was undertaken when requested. All positive findings in the screen were subsequently confirmed and quantitated using validated liquid chromatography tandem mass spectrometry (LC-MS/MS) methods.
In two of the 11 cases, plastic bags labeled as "U-47700" were located during scene investigation (Images 1 and 2), which was helpful in prompting additional analysis. Fortunately, the plastic bags were labeled appropriately with its correct contents as verified by toxicology testing; it is not uncommon for substances distributed on the black market to have missing, incorrect, or misleading information on their packaging. Specialized testing for U-47700 and furanyl fentanyl was pursued upon request of the medical examiner using a de novo method previously described (3) .
RESULTS
Blood samples from 11 cases relating to deaths involving furanyl fentanyl and/or U-47700 were submitted for quantitative analysis for U-47700 or furanyl fentanyl. These deaths occurred between May 2015 and October 2016. Table 1 details the specifics of the 11 cases.
DISCUSSION
This report details a series of 11 deaths from Tennessee where novel illicit opioids U-47700 and furanyl fentanyl were implicated in toxicology findings and considered causative in the deaths. Two cases were positive for U-47700, with concentrations of 547 and 189 ng/mL in femoral blood. Nine other cases
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were positive for furanyl fentanyl, with concentrations ranging from 2.0 to 42.9 ng/mL and an average concentration of 9.7 ng/mL (median 6.9 ng/mL). All manners of death were classified as accident. These concentrations are consistent with quantitative results previously reported by the authors (U-47700, 17-490 ng/mL; furanyl fentanyl, 2.5-76 ng/mL) (3).
Opiates have, over the course of time, been among the most frequently encountered substances in drug-related deaths (30) (31) (32) (33) (34) . In recent years, deaths related to NPS such as 5-IT (35, 36) , methylone (37-39), methoxetamine (40) , methylenedioxypyrovalerone (MDPV) (41) , methedrone (42) , and para-methoxymethamphetamine (PMMA) (43) have been previously reported. Other NPS have previously been reported in Tennessee (44) , but this is the first published postmortem case series from the state involving novel illicit opioids. Deaths caused by NPS continue to be a problem for death investigators, medical examiners, and toxicology laboratories. Identification of the causal agents typically involves extensive additional investigation and often requires development and on-the-fly validation of new toxicological assays if and when certified standard reference materials are available, which can often lag the casework findings by weeks or months. In addition, as demonstrated by this case series, the autopsy findings (e.g., pulmonary edema and histologic evidence of polarizable material in the lungs) in deaths caused by NPS are nonspecific and similar to those seen in deaths due to other drugs. Scene investigation is extremely important for all potential drug-related deaths. The successful identification of pertinent substances in toxicology, especially those considered to be NPS, typically require additional targeted testing. Often, this targeted testing is dependent solely on investigative information from Image 1: Plastic baggie labeled U-47700 containing white powder.
the scene, and requires the appropriate communication between scene investigators, medical examiners, forensic pathologists, and toxicologists to ensure the appropriate testing in completed. In several of the cases described here, baggies of drugs were collected at the scene or found in the decedent's possession; these appropriately labeled products helped to alert the medical examiner to request specialized toxicological testing, since most newer substances would not be covered under routine toxicology testing. Specialized toxicological testing for novel illicit opioids is also recommended in suspected opiate overdose cases when routine testing does not confirm the presence of any causative agents. Positive but unconfirmed fentanyl screens may provide some insight into the presence of a fentanyl derivative such as furanyl fentanyl, since many of the fentanyl derivatives have some degree of cross-reactivity with fentanyl targeted immunoassays (45) .
All 11 cases reported were positive for at least one other substance, and polysubstance abuse cases involving NPS are always difficult to interpret since little information is available regarding toxicity of individual substances. Of the 11 reported cases, six included other opioids, and two of those cases reported 6-monoacetylmorphine (6-MAM) in vitreous. It could not be determined in either case if the furanyl fentanyl detected was a concomitant exposure with the heroin, or if the drugs were taken at separate times. In Case 5, in addition to the detection of morphine in blood and 6-MAM in vitreous, the cocaine metabolite benzoylecgonine was detected, and since the blood was collected in a blue top tube, the sample lacked the proper preservative to inhibit the degradation of cocaine to its inactive metabolite. Furanyl fentanyl has been found as a contaminant in crack cocaine in a series of overdose events in British Columbia (46) . There was no apparent pattern of polysubstance abuse among these Individual was found dead in bed at home. He was supine with dried white froth on his mouth and nose. His history included report of a "chest cold" with fever and sore throat shortly prior to death. Several plastic baggies labeled as "U-47700", "etizolam", "butyrfentanyl", and "4-2CO-MET" were found in decedent's room. Drug paraphernalia (e.g., cut straws, crushed white powder, needles, and syringes) were also found near the decedent. Individual was found dead lying in the floor of his bedroom at home. He was last known alive, when he was "falling asleep" while trying to eat, approximately three hours prior to being found. Hydrocodone, oxycodone, and other nonopiate medications prescribed for the decedent were found at the scene. Drug paraphernalia were not present. His medical history was significant for hypertension, "cardiac problems", and chronic pain. An autopsy was not performed. 

cases, as other findings varied from other opioids as listed previously, stimulants such as methamphetamine, benzodiazepines including etizolam, prescription medications, marijuana, alcohol, and others.
CONCLUSION
Postmortem cases involving NPS, including the novel illicit opioids furanyl fentanyl and U-47700, continue to pose challenges. This case series highlights the successful collaboration between scene investigators, forensic pathologists, and toxicologists in identifying novel illicit opioids in addition to routine toxicological findings, therefore resulting in a comprehensive death investigation. The collaborative nature of these types of investigations will continue to be needed for the successful resolution of NPS type cases as more and more novel illicit opioids appear in death investigations.
